| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA807: Roxadustat for treating symptomatic anaemia in chronic kidney disease |
|
Medicine details |
|
| Medicine name | roxadustat (Evrenzo®) |
| Formulation | 20mg,50mg,70mg,100mg,150mg film coated tablets |
| Reference number | 2099 |
| Indication | First-line treatment of anaemia in patients with chronic kidney disease |
| Company | Astellas Pharma Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/06/2021 |
| NICE guidance | TA807: Roxadustat for treating symptomatic anaemia in chronic kidney disease |